Role of nicotinamide N-methyltransferase in non-small cell lung cancer: In vitro effect of shRNA-mediated gene silencing on tumourigenicity

Biological Chemistry

Volumn 396, Issue 3, 2015, Pages 225-234

  Sartini, Davide ^a   Seta, Riccardo ^a   Pozzi, Valentina ^a   Morganti, Stefano ^a   Rubini, Corrado ^a   Zizzi, Antonio ^a   Tomasetti, Marco ^a   Santarelli, Lory ^a   Emanuelli, Monica ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

anchorage independent cell growth; cancer cell line; cell proliferation; knockdown; nicotinamide N methyltransferase (NNMT); non small cell lung cancer (NSCLC)

Indexed keywords

NICOTINAMIDE METHYLTRANSFERASE; SHORT HAIRPIN RNA; SMALL INTERFERING RNA;

A549 CELL LINE; ANCHORAGE INDEPENDENT GROWTH; ARTICLE; CANCER GROWTH; CANCER PATIENT; CELL PROLIFERATION; CLINICAL ARTICLE; COLONY FORMATION; DOWN REGULATION; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LUNG CARCINOGENESIS; NON SMALL CELL LUNG CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; ADULT; AGED; CARCINOGENESIS; CELL ADHESION; ENZYMOLOGY; FEMALE; LUNG TUMOR; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; TUMOR CELL LINE;

ADULT; AGED; CARCINOGENESIS; CARCINOMA, NON-SMALL-CELL LUNG; CELL ADHESION; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GENE KNOCKDOWN TECHNIQUES; GENE SILENCING; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; NICOTINAMIDE N-METHYLTRANSFERASE; RNA, SMALL INTERFERING;

EID: 84922513739     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/hsz-2014-0231     Document Type: Article

References (40)

1. Aksoy, S., Szumlanski, C.L., and Weinshilboum, R.M. (1994). Human liver nicotinamide N-methyltransferase. cDNA cloning, expression, and biochemical characterization. J. Biol. Chem. 269, 14835-14840.
2. Audrito, V., Vaisitti, T., Rossi, D., Gottardi, D., D'Arena, G., Laurenti, L., Gaidano, G., Malavasi, F., and Deaglio, S. (2011). Nicotinamide blocks proliferation and induces apoptosis of chronic lymphocytic leukemia cells through activation of the p53/miR-34a/SIRT1 tumor suppressor network. Cancer Res. 71, 4473-4483.
3. Balducci, E., Emanuelli, M., Raffaelli, N., Ruggieri, S., Amici, A., Magni, G., Orsomando, G., Polzonetti, V., and Natalini, P. (1995). Assay methods for nicotinamide mononucleotide adenylyltransferase of wide applicability. Anal. Biochem. 228, 64-68.
4. Bartus, M., Lomnicka, M., Kostogrys, R.B., Kazmierczak, P., Watala, C., Slominska, E.M., Smolenski, R.T., Pisulewski, P.M., Adamus, J., Gebicki, J., et al. (2008). 1-Methylnicotinamide (MNA) prevents endothelial dysfunction in hypertriglyceridemic and diabetic rats. Pharmacol. Rep. 60, 127-138.
5. Bradford, M.M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
6. Brzozowski, T., Konturek, P.C., Chlopicki, S., Sliwowski, Z., Pawlik, M., Ptak-Belowska, A., Kwiecien, S., Drozdowicz, D., Pajdo, R., Slonimska, E., et al. (2008). Therapeutic potential of 1-methylnicotinamide against acute gastric lesions induced by stress: role of endogenous prostacyclin and sensory nerves. J. Pharmacol. Exp. Ther. 326, 105-116.
7. Chlopicki, S., Swies, J., Mogielnicki, A., Buczko, W., Bartus, M., Lomnicka, M., Adamus, J., and Gebicki, J. (2007). 1-Methylnicotinamide (MNA), a primary metabolite of nicotinamide, exerts anti-thrombotic activity mediated by a cyclooxygenase-2/prostacyclin pathway. Br. J. Pharmacol. 152, 230-239.
8. D'Andrea, F.P., Safwat, A., Kassem, M., Gautier, L., Overgaard, J., and Horsman, M.R. (2011). Cancer stem cell overexpression of nicotinamide N-methyltransferase enhances cellular radiation resistance. Radiother. Oncol. 99, 373-378.
9. Debigaré, R., Maltais, F., Côté, C.H., Michaud, A., Caron, M.A., Mofarrahi, M., Leblanc, P., and Hussain, S.N. (2008). Profiling of mRNA expression in quadriceps of patients with COPD and muscle wasting. COPD. 5, 75-84.
10. Emanuelli, M., Santarelli, A., Sartini, D., Ciavarella, D., Rossi, V., Pozzi, V., Rubini, C., and Lo Muzio, L. (2010). Nicotinamide N-Methyltransferase upregulation correlates with tumour differentiation in oral squamous cell carcinoma. Histol. Histopathol. 25, 15-20.
11. Kim, H.C., Mofarrahi, M., Vassilakopoulos, T., Maltais, F., Sigala, I., Debigare, R., Bellenis, I., and Hussain, S.N. (2010). Expression and functional significance of nicotinamide N-methyl transferase in skeletal muscles of patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 181, 797-805.
12. Lim, B.H., Cho, B.I., Kim, Y.N., Kim, J.W., Park, S.T., and Lee, C.W. (2006). Overexpression of nicotinamide N-methyltransferase in gastric cancer tissues and its potential post-translational modification. Exp. Mol. Med. 38, 455-465.
13. Liu, Y., He, S., Ding, Y., Huang, J., Zhang, Y., and Chen, L. (2014). The efficacy and safety of thalidomide-based therapy in patients with advanced non-small cell lung cancer: a meta-analysis. Contemp. Oncol. 18, 39-47.
14. Markert, J.M., Fuller, C.M., Gillespie, G.Y., Bubien, J.K., McLean, L.A., Hong, R.L., Lee, K., Gullans, S.R., Mapstone, T.B., and Benos, D.J. (2001). Differential gene expression profiling in human brain tumors. Physiol. Genomics. 5, 21-33.
15. Mateuszuk, L., Khomich, T.I., Slominska, E., Gajda, M., Wójcik, L., lomnicka, M., Gwózdz, P., and Chlopicki, S. (2009). Activation of nicotinamide N-methyltrasferase and increased formation of 1-methylnicotinamide (MNA) in atherosclerosis. Pharmacol. Rep. 61, 76-85.
16. Milani, Z.H., Ramsden, D.B., and Parsons, R.B. (2013). Neuroprotective effects of nicotinamide N-methyltransferase and its metabolite 1-methylnicotinamide. J. Biochem. Mol. Toxicol. 27, 451-456.
17. Niklinski, J. and Hirsch, F.R. (2002). Molecular approaches to lung cancer evaluation. Lung Cancer. 38, S9-S17.
18. Parsons, R.B., Smith, M.L., Williams, A.C., Waring, R.H., and Ramsden, D.B. (2002). Expression of nicotinamide N-methyltransferase (E.C. 2.1.1.1) in the Parkinsonian brain. J. Neuropathol. Exp. Neurol. 61, 111-124.
19. Parsons, R.B., Aravindan, S., Kadampeswaran, A., Evans, E.A., Sandhu, K.K., Levy, E.R., Thomas, M.G., Austen, B.M., and Ramsden, D.B. (2011). The expression of nicotinamide N-methyltransferase increases ATP synthesis and protects SH-SY5Y neuroblastoma cells against the toxicity of Complex I inhibitors. Biochem. J. 436, 145-155.
20. Pei, B.X., Sun, B.S., Zhang, Z.F., Wang, A.L., and Ren, P. (2014). Interstitial tumor-associated macrophages combined with tumor-derived colony-stimulating factor-1 and interleukin-6, a novel prognostic biomarker in non-small cell lung cancer. J. Thorac. Cardiovasc. Surg. In press.
21. Peng, Y., Sartini, D., Pozzi, V., Wilk, D., Emanuelli, M., and Yee, V.C. (2011). Structural basis of substrate recognition in human nicotinamide N-methyltransferase. Biochemistry. 50, 7800-7808.
22. Pozzi, V., Mazzotta, M., Lo Muzio, L., Sartini, D., Santarelli, A., Renzi, E., Rocchetti, R., Tomasetti, M., Ciavarella, D., and Emanuelli, M. (2011). Inhibiting proliferation in KB cancer cells by RNA interference-mediated knockdown of nicotinamide N-methyltransferase expression. Int. J. Immunopathol. Pharmacol. 24, 69-77.
23. Pozzi, V., Sartini, D., Morganti, S., Giuliante, R., Di Ruscio, G., Santarelli, A., Rocchetti, R., Rubini, C., Tomasetti, M., Giannatempo, G., et al. (2013). RNA-mediated gene silencing of nicotinamide N-methyltransferase is associated with decreased tumorigenicity in human oral carcinoma cells. PLoS One. 8, e71272.
24. Roessler, M., Rollinger, W., Palme, S., Hagmann, M.L., Berndt, P., Engel, A.M., Schneidinger, B., Pfeffer, M., Andres, H., Karl, J., et al. (2005). Identification of nicotinamide N-methyltransferase as a novel serum tumor marker for colorectal cancer. Clin. Cancer Res. 11, 6550-6557.
25. Rogers, C.D., Fukushima, N., Sato, N., Shi, C., Prasad, N., Hustinx, S.R., Matsubayashi, H., Canto, M., Eshleman, J.R., Hruban, R.H., et al. (2006). Differentiating pancreatic lesions by microarray and QPCR analysis of pancreatic juice RNAs. Cancer. Biol. Ther. 5, 1383-1389.
26. Sartini, D., Muzzonigro, G., Milanese, G., Pierella, F., Rossi, V., and Emanuelli, M. (2006). Identification of nicotinamide N-methyltransferase as a novel tumor marker for renal clear cell carcinoma. J. Urol. 176, 2248-2254.
27. Sartini, D., Santarelli, A., Rossi, V., Goteri, G., Rubini, C., Ciavarella, D., Lo Muzio, L., and Emanuelli, M. (2007). Nicotinamide N-methyltransferase upregulation inversely correlates with lymph node metastasis in oral squamous cell carcinoma. Mol. Med. 13, 415-421.
28. Sartini, D., Pozzi, V., Renzi, E., Morganti, S., Rocchetti, R., Rubini, C., Santarelli, A., Lo Muzio, L., and Emanuelli, M. (2012). Analysis of tissue and salivary nicotinamide N-methyltransferase in oral squamous cell carcinoma: basis for the development of a noninvasive diagnostic test for early-stage disease. Biol. Chem. 393, 505-11.
29. Sartini, D., Muzzonigro, G., Milanese, G., Pozzi, V., Vici, A., Morganti, S., Rossi, V., Mazzucchelli, R., Montironi, R., and Emanuelli, M. (2013a). Upregulation of tissue and urinary nicotinamide N-methyltransferase in bladder cancer: potential for the development of a urine-based diagnostic test. Cell Biochem. Biophys. 65, 473-483.
30. Sartini, D., Morganti, S., Guidi, E., Rubini, C., Zizzi, A., Giuliante, R., Pozzi, V., and Emanuelli, M. (2013b). Nicotinamide N-methyltransferase in non-small cell lung cancer: promising results for targeted anti-cancer therapy. Cell Biochem. Biophys. 67, 865-873.
31. Sternak, M., Khomich, T.I., Jakubowski, A., Szafarz, M., Szczepanski, W., Bialas, M., Stojak, M., Szymura-Oleksiak, J., and Chlopicki, S. (2010). Nicotinamide N-methyltransferase (NNMT) and 1-methylnicotinamide (MNA) in experimental hepatitis induced by concanavalin A in the mouse. Pharmacol. Rep. 62, 483-493.
32. Sun, S., Schiller, J.H., Spinola, M., and Minna, J.D. (2007). New molecularly targeted therapies for lung cancer. J. Clin. Invest. 117, 2740-2750.
33. Tang, S.W., Yang, T.C., Lin, W.C., Chang, W.H., Wang, C.C., Lai, M.K., and Lin, J.Y. (2011). Nicotinamide N-methyltransferase induces cellular invasion through activating matrix metalloproteinase-2 expression in clear cell renal cell carcinoma cells. Carcinogenesis. 32, 138-145.
34. Ulanovskaya O.A., Zuhl A.M., and Cravatt B.F. (2013). NNMT promotes epigenetic remodeling in cancer by creating a metabolic methylation sink. Nat. Chem. Biol. 9, 300-306.
35. Wu, Y., Siadaty, M.S., Berens, M.E., Hampton, G.M., and Theodorescu, D. (2008). Overlapping gene expression profiles of cell migration and tumor invasion in human bladder cancer identify metallothionein 1E and nicotinamide N-methyltransferase as novel regulators of cell migration. Oncogene. 27, 6679-6689.
36. Xu, J., Moatamed, F., Caldwell, J.S., Walker, J.R., Kraiem, Z., Taki, K., Brent, G.A., and Hershman, J.M. (2003). Enhanced expression of nicotinamide N-methyltransferase in human papillary thyroid carcinoma cells. J. Clin. Endocrinol. Metab. 88, 4990-4996.
37. Zhang, J. (2003). Are poly(ADP-ribosyl)ation by PARP-1 and deacetylation by Sir2 linked? Bioessays. 25, 808-814.
38. Zhang, J., Wang, Y., Li, G., Yu, H., and Xie, X. (2014a). Down-regulation of nicotinamide N-methyltransferase induces apoptosis in human breast cancer cells via the mitochondria-mediated pathway. PLoS One. 9, e89202.
39. Zhang, E.B., Yin, D.D., Sun, M., Kong, R., Liu, X.H., You, L.H., Han, L., Xia, R., Wang, K.M., Yang, J.S., et al. (2014b). P53-regulated long non-coding RNA TUG1 affects cell proliferation in human non-small cell lung cancer, partly through epigenetically regulating HOXB7 expression. Cell Death Dis. 22, e1243.
40. Zhao, D.P., Yang, C.L., Zhou, X., Ding, J.A., and Jiang, G.N. (2014). Association between CLPTM1L polymorphisms (rs402710 and rs401681) and lung cancer susceptibility: evidence from 27 case-control studies. Mol. Genet. Genomics. In press.